Bergeron A - Search Results

1

The estrogen signaling pathway reprograms prostate cancer cell metabolism and supports proliferation and disease progression.

Lafront C, Germain L, Campolina-Silva GH, Weidmann C, Berthiaume L, Hovington H, Brisson H, Jobin C, Frégeau-Proulx L, Cotau R, Gonthier K, Lacouture A, Caron P, Ménard C, Atallah C, Riopel J, Latulippe É, Bergeron A, Toren P, Guillemette C, Pelletier M, Fradet Y, Belleannée C, Pouliot F, Lacombe L, Lévesque É, Audet-Walsh É. Lafront C, et al. Among authors: bergeron a. J Clin Invest. 2024 Apr 16:e170809. doi: 10.1172/JCI170809. Online ahead of print. J Clin Invest. 2024. PMID: 38625747 Free article.

2

Identification of a superficial bladder tumor-associated glycoform of the carcinoembryonic antigen by monoclonal antibody 19A211.

Bergeron A, LaRue H, Fradet Y. Bergeron A, et al. Cancer Res. 1996 Feb 15;56(4):908-15. Cancer Res. 1996. PMID: 8631032

3

Biochemical analysis of a bladder-cancer-associated mucin: structural features and epitope characterization.

Bergeron A, LaRue H, Fradet Y. Bergeron A, et al. Biochem J. 1997 Feb 1;321 ( Pt 3)(Pt 3):889-95. doi: 10.1042/bj3210889. Biochem J. 1997. PMID: 9032480 Free PMC article.

4

Polymorphisms of the human NRAMP1 gene are associated with response to bacillus Calmette-Guerin immunotherapy for superficial bladder cancer.

Decobert M, Larue H, Bergeron A, Harel F, Pfister C, Rousseau F, Lacombe L, Fradet Y. Decobert M, et al. Among authors: bergeron a. J Urol. 2006 Apr;175(4):1506-11. doi: 10.1016/S0022-5347(05)00653-1. J Urol. 2006. PMID: 16516037

5

Cancer-testis antigen expression in bladder cancer.

Fradet Y, Picard V, Bergeron A, LaRue H. Fradet Y, et al. Among authors: bergeron a. Prog Urol. 2005 Dec;15(6 Suppl 1):1303-13. Prog Urol. 2005. PMID: 16734221

6

Cancer-testis antigen expression in bladder cancer.

Fradet Y, Picard V, Bergeron A, LaRue H. Fradet Y, et al. Among authors: bergeron a. Prog Urol. 2006 Sep;16(4):421-8. Prog Urol. 2006. PMID: 17069033 No abstract available.

7

MAGE-A9 mRNA and protein expression in bladder cancer.

Picard V, Bergeron A, Larue H, Fradet Y. Picard V, et al. Among authors: bergeron a. Int J Cancer. 2007 May 15;120(10):2170-7. doi: 10.1002/ijc.22282. Int J Cancer. 2007. PMID: 17290406 Free article.

8

Bladder tumor infiltrating mature dendritic cells and macrophages as predictors of response to bacillus Calmette-Guérin immunotherapy.

Ayari C, LaRue H, Hovington H, Decobert M, Harel F, Bergeron A, Têtu B, Lacombe L, Fradet Y. Ayari C, et al. Among authors: bergeron a. Eur Urol. 2009 Jun;55(6):1386-95. doi: 10.1016/j.eururo.2009.01.040. Epub 2009 Feb 3. Eur Urol. 2009. PMID: 19193487

9

High frequency of MAGE-A4 and MAGE-A9 expression in high-risk bladder cancer.

Bergeron A, Picard V, LaRue H, Harel F, Hovington H, Lacombe L, Fradet Y. Bergeron A, et al. Int J Cancer. 2009 Sep 15;125(6):1365-71. doi: 10.1002/ijc.24503. Int J Cancer. 2009. PMID: 19533752 Free article.

10

Toll-like receptors in normal and malignant human bladders.

Ayari C, Bergeron A, LaRue H, Ménard C, Fradet Y. Ayari C, et al. Among authors: bergeron a. J Urol. 2011 May;185(5):1915-21. doi: 10.1016/j.juro.2010.12.097. Epub 2011 Mar 21. J Urol. 2011. PMID: 21421234

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

548 results

Search Page